There were 7 cases of PAH temporally associated with bevacizumab in the French Pulmonary Hypertension Registry, but most had predisposing conditions. Bevacizumab exposure does not seem to lead to the ...

Only 26.0% of respondents’ hospitals had dedicated pediatric sedation centers, and just 19.7% had specialized rare disease clinics. A cross-sectional survey of anesthesia practitioners in China ...

The prevalence of irregular red cell alloantibodies was 8.04% in pediatric patients, with anti-E and anti-Mi antibodies the most common. Pediatric patients can develop irregular, non-ABO red cell ...

Findings from receiver operating characteristic analysis identified transferrin cutoff values of 194.0 mg/dL for differentiating active AAV from remission AAV and 259.5 mg/dL for distinguishing those ...

For PBC, the phase 3 GLISTEN trial of linerixibat showed a significant pruritus improvement, with an adjusted mean difference of –0.72 on the Worst Itch Numeric Rating Scale. Ileal bile acid ...

AI could transform where pregnant women are cared for, how they are cared for, and who delivers prenatal care. Artificial intelligence (AI) can revolutionize the clinical approach to pregnancy care ...

The researchers identified 158 mtDNA variants across samples, with a higher variant burden in stillbirth cases without cardiac conduction system abnormalities. Mitochondrial DNA (mtDNA) alterations ...

The relative left ventricular wall thickness, indicating relative wall thickening, was significantly higher in patients who were technetium-99m pyrophosphate (99mTc-PYP) positive compared with ...

There is a dichotomy in quality-of-life outcomes in patients with PAH, with significant physical impairments and relatively preserved mental health scores. Patient-reported outcome measures play a key ...

Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

The US Food and Drug Administration (FDA) has approved the clinical trial application of an 9MW3811 injection for idiopathic pulmonary fibrosis (IPF), announced Mabwell. China’s first antibody against ...

Individuals with advanced liver disease may also experience significant weight loss due to nausea and poor appetite. Candidates for liver transplantation may need to gain weight to optimize surgical ...